WS #11204
FDA approved Casgevy (exagamglogene autotemcel) for children aged 2+ with sickle cell disease, expanding Vertex's market.
FDA Approval for Vertex Gene Therapy
FDA approved Casgevy (exagamglogene autotemcel) for children aged 2+ with sickle cell disease, expanding Vertex's market.